IDH1 and glioblastoma: Low efficacy of penfluridol against pediatric tumor may in part be attributed to the fact that one third of pediatric glioblastoma is characterized by H3F3A mutations, whereas IDH1-mutated glioblastoma is common in adult patients [22].